Insider · CIK 0001224108

CAPELLO JEFFREY D

Reports to the SEC for 8 companies · LANSING, MI

sec.gov

Transactions

Companies

Filings

CIK

0001224108

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	NEOGNEOGEN CORP · Common Stock (Right to Buy)A Award	Director	AAward	+20.6K sh	—	—	20,558
2026-10-01	NEOGNEOGEN CORPA Award	Director	AAward	+9,804 sh	$12.24	+$120K	42,306
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15K sh	—	—	14,950
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,816 sh	—	—	10,865
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,816 sh	—	—	0
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,927 sh	—	—	2,927
2026-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,976 sh	—	—	0
2026-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,976 sh	—	—	8,049
2025-10-27	NEOGNEOGEN CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,777 sh	$6.19	−$11K	1,777
2025-10-27	NEOGNEOGEN CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,025 sh	$6.19	−$12.5K	4,050
2025-10-27	NEOGNEOGEN CORPM Exercise/Conversion	Director	MExercise/Conversion	+1,777 sh	$6.19	+$11K	32,502
2025-10-27	NEOGNEOGEN CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,025 sh	$6.19	+$12.5K	30,725
2025-10-23	NEOGNEOGEN CORP · Common Stock (Right to Buy)A Award	Director	AAward	+50.8K sh	—	—	50,814
2025-10-23	NEOGNEOGEN CORPA Award	Director	AAward	+19.8K sh	$6.07	+$120K	48,469
2025-10-07	NEOGNEOGEN CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,071 sh	$5.63	+$11.7K	28,700
2025-10-07	NEOGNEOGEN CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,071 sh	$5.63	−$11.7K	0
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,120 sh	—	—	0
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,120 sh	—	—	6,073
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,861 sh	—	—	2,861
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15.8K sh	—	—	15,768
2025-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,977 sh	—	—	1,976
2025-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,977 sh	—	—	3,953
2025-04-22	NEOGNEOGEN CORPP Purchase	Director	PPurchase	+20.7K sh	$4.84	+$100K	26,629
2024-10-28	NEOGNEOGEN CORPM Exercise/Conversion	Director	MExercise/Conversion	+1,776 sh	$13.81	+$24.5K	5,917
2024-10-28	NEOGNEOGEN CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,776 sh	$13.81	−$24.5K	3,552
2024-10-24	NEOGNEOGEN CORP · Common Stock (Right to Buy)A Award	Director	AAward	+18.7K sh	—	—	18,653
2024-10-24	NEOGNEOGEN CORPA Award	Director	AAward	+6,075 sh	$13.58	+$82.5K	15,840
2024-10-07	NEOGNEOGEN CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,070 sh	$15.07	−$31.2K	2,071
2024-10-07	NEOGNEOGEN CORPM Exercise/Conversion	Director	MExercise/Conversion	+2,070 sh	$15.07	+$31.2K	4,141
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+11.8K sh	—	—	11,774
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,120 sh	—	—	2,120
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,976 sh	—	—	3,953
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,976 sh	—	—	1,976
2023-10-26	NEOGNEOGEN CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+5,329 sh	—	—	9,470
2023-10-26	NEOGNEOGEN CORP · Common Stock (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+13.7K sh	—	—	32,132
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+33.2K sh	—	—	33,177
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+5,929 sh	—	—	5,929
2022-10-06	NEOGNEOGEN CORP · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	+6,212 sh	—	—	6,212
2022-10-06	NEOGNEOGEN CORP · Common Stock (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+18.4K sh	—	—	18,416
2020-02-12	BIIBBIOGEN INC. · Restricted Stock UnitJ Other	EVP & Chief Financial Officer	JOther	−2,253 sh	—	—	8,348
2020-02-12	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−1,919 sh	—	—	10,601
2020-02-12	BIIBBIOGEN INC. · Restricted Stock UnitA Award	EVP & Chief Financial Officer	AAward	+10.6K sh	—	—	10,550
2020-02-12	BIIBBIOGEN INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−614 sh	$331.76	−$204K	3,118
2020-02-12	BIIBBIOGEN INC.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+1,919 sh	—	—	3,732
2020-01-02	BIIBBIOGEN INC.F Tax Payment	EVP & Chief Financial Officer	FTax Payment	−406 sh	$294.20	−$119K	1,813
2020-01-02	BIIBBIOGEN INC.M Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	+1,302 sh	—	—	2,219
2020-01-02	BIIBBIOGEN INC. · Restricted Stock UnitJ Other	EVP & Chief Financial Officer	JOther	−1,690 sh	—	—	2,996
2020-01-02	BIIBBIOGEN INC. · Restricted Stock UnitM Exercise/Conversion	EVP & Chief Financial Officer	MExercise/Conversion	−1,302 sh	—	—	4,686
2019-02-12	BIIBBIOGEN INC. · Restricted Stock UnitA Award	EVP & Chief Financial Officer	AAward	+12.5K sh	—	—	12,520
2019-01-02	BIIBBIOGEN INC. · Restricted Stock UnitJ Other	EVP & Chief Financial Officer	JOther	−1,661 sh	—	—	5,988

Recent filings

Accepted (ET)
Oct 24
CAPELLO JEFFREY D0000711377-26-000022
SEC(opens sec.gov)
Jun 234
CAPELLO JEFFREY D0001439222-26-000105
SEC(opens sec.gov)
Jun 164
CAPELLO JEFFREY D0001439222-26-000075
SEC(opens sec.gov)
Oct 294
CAPELLO JEFFREY D0000711377-25-000071
SEC(opens sec.gov)
Oct 284
CAPELLO JEFFREY D0000711377-25-000060
SEC(opens sec.gov)
Oct 274
CAPELLO JEFFREY D0000711377-25-000051
SEC(opens sec.gov)
Oct 94
CAPELLO JEFFREY D0000711377-25-000037
SEC(opens sec.gov)
Jun 234
CAPELLO JEFFREY D0001439222-25-000059
SEC(opens sec.gov)

Companies

Address

C/O NEOGEN CORP. 620 LESHER PLACE

LANSING, MI, 48912